Inventor
Aeri Kim
Inventor
Daejeon, KR
Overview
Patents· 11 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%
C08FMacromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds17%
C07DHeterocyclic compounds10%
C07BGeneral methods of organic chemistry7%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
C01GCompounds containing metals not covered by subclasses c01d or c01f3%
C07CAcyclic or carbocyclic compounds3%
C08LCompositions of macromolecular compounds3%
PatentTitleYear
10,800,863Transition metal complexes, catalyst compositions including the same, and method for preparing polyolefins therewith202010,683,268Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt202010,487,053Acid addition salt of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine201910,336,695Crystalline form of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamine salt201910,280,236Ligand compound, transition metal compound and catalyst composition including the transition metal compound201910,093,755Ligand compound, transition metal compound and catalyst composition including the transition metal compound20189,822,200'Ligand compound, transition metal compound, and catalystic composition including the same'20179,376,519'Transition metal compound, catalytic composition including the same, and method for preparing polymer using the same'20167,097,967'Method of predicting drug-food interaction'20065,658,587'Transdermal delivery of alpha adrenoceptor blocking agents'19975,503,843'Transdermal delivery of alpha adrenoceptor blocking agents'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–1997Patents assigned to FLORA INC (2)· patent assignee history
1996Based in Mountain View, CA, US· patent location history
1997Based in Taejon, KR· patent location history
2006Patents assigned to LG LIFE SCIENCES LTD (1)· patent assignee history
2006–2020Based in Daejeon, KR· patent location history
2016–2020Patents assigned to LG CHEMICAL LTD (5)· patent assignee history
2019–2020Patents assigned to DAE WOONG PHARMA (3)· patent assignee history
2019–2020Based in Seoul, KR· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| LG CHEMICAL LTD | 5 | 2016–2020 |
| DAE WOONG PHARMA | 3 | 2019–2020 |
| FLORA INC | 2 | 1996–1997 |
| LG LIFE SCIENCES LTD | 1 | 2006 |
Locations
| Location | Patents | Span |
|---|---|---|
| Daejeon, KR | 6 | 2006–2020 |
| Seoul, KR | 3 | 2019–2020 |
| Taejon, KR | 1 | 1997 |
| Mountain View, California, US | 1 | 1996 |